The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Psoriatic Arthritis Therapeutics Market Research Report 2024
Synopsis
Psoriatic arthritis is a long-term inflammatory arthritis that occurs in people affected by the autoimmune disease psoriasis.
The global Psoriatic Arthritis Therapeutics market was valued at US$ 6400 million in 2023 and is anticipated to reach US$ 11750 million by 2030, witnessing a CAGR of 9.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Psoriatic Arthritis Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Psoriatic Arthritis Therapeutics.
Report Scope
The Psoriatic Arthritis Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Psoriatic Arthritis Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Psoriatic Arthritis Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Bayer
Novartis
Abbott Laboratories
Sanofi
Bristol-Myers Squibb
Janssen Biotech
Amgen
UCB
AbbVie
Segment by Type
Nonsteroidal Anti-Inflammatory Drug
Disease-Modifying Antirheumatic Drug
Biologic Drug
Enzyme Inhibitor
Segment by Application
Hospitals
Clinics
Research Labs
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Psoriatic Arthritis Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Psoriatic arthritis is a long-term inflammatory arthritis that occurs in people affected by the autoimmune disease psoriasis.
The global Psoriatic Arthritis Therapeutics market was valued at US$ 6400 million in 2023 and is anticipated to reach US$ 11750 million by 2030, witnessing a CAGR of 9.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Psoriatic Arthritis Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Psoriatic Arthritis Therapeutics.
Report Scope
The Psoriatic Arthritis Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Psoriatic Arthritis Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Psoriatic Arthritis Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Bayer
Novartis
Abbott Laboratories
Sanofi
Bristol-Myers Squibb
Janssen Biotech
Amgen
UCB
AbbVie
Segment by Type
Nonsteroidal Anti-Inflammatory Drug
Disease-Modifying Antirheumatic Drug
Biologic Drug
Enzyme Inhibitor
Segment by Application
Hospitals
Clinics
Research Labs
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Psoriatic Arthritis Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Psoriatic Arthritis Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Nonsteroidal Anti-Inflammatory Drug
1.2.3 Disease-Modifying Antirheumatic Drug
1.2.4 Biologic Drug
1.2.5 Enzyme Inhibitor
1.3 Market by Application
1.3.1 Global Psoriatic Arthritis Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Labs
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Psoriatic Arthritis Therapeutics Market Perspective (2019-2030)
2.2 Psoriatic Arthritis Therapeutics Growth Trends by Region
2.2.1 Global Psoriatic Arthritis Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Psoriatic Arthritis Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Psoriatic Arthritis Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Psoriatic Arthritis Therapeutics Market Dynamics
2.3.1 Psoriatic Arthritis Therapeutics Industry Trends
2.3.2 Psoriatic Arthritis Therapeutics Market Drivers
2.3.3 Psoriatic Arthritis Therapeutics Market Challenges
2.3.4 Psoriatic Arthritis Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Psoriatic Arthritis Therapeutics Players by Revenue
3.1.1 Global Top Psoriatic Arthritis Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Psoriatic Arthritis Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Psoriatic Arthritis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Psoriatic Arthritis Therapeutics Revenue
3.4 Global Psoriatic Arthritis Therapeutics Market Concentration Ratio
3.4.1 Global Psoriatic Arthritis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Psoriatic Arthritis Therapeutics Revenue in 2023
3.5 Psoriatic Arthritis Therapeutics Key Players Head office and Area Served
3.6 Key Players Psoriatic Arthritis Therapeutics Product Solution and Service
3.7 Date of Enter into Psoriatic Arthritis Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Psoriatic Arthritis Therapeutics Breakdown Data by Type
4.1 Global Psoriatic Arthritis Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Psoriatic Arthritis Therapeutics Forecasted Market Size by Type (2025-2030)
5 Psoriatic Arthritis Therapeutics Breakdown Data by Application
5.1 Global Psoriatic Arthritis Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Psoriatic Arthritis Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Psoriatic Arthritis Therapeutics Market Size (2019-2030)
6.2 North America Psoriatic Arthritis Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Psoriatic Arthritis Therapeutics Market Size by Country (2019-2024)
6.4 North America Psoriatic Arthritis Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Psoriatic Arthritis Therapeutics Market Size (2019-2030)
7.2 Europe Psoriatic Arthritis Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Psoriatic Arthritis Therapeutics Market Size by Country (2019-2024)
7.4 Europe Psoriatic Arthritis Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Psoriatic Arthritis Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Psoriatic Arthritis Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Psoriatic Arthritis Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Psoriatic Arthritis Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Psoriatic Arthritis Therapeutics Market Size (2019-2030)
9.2 Latin America Psoriatic Arthritis Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Psoriatic Arthritis Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Psoriatic Arthritis Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Psoriatic Arthritis Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Psoriatic Arthritis Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Psoriatic Arthritis Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Psoriatic Arthritis Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Psoriatic Arthritis Therapeutics Introduction
11.1.4 Pfizer Revenue in Psoriatic Arthritis Therapeutics Business (2019-2024)
11.1.5 Pfizer Recent Development
11.2 Bayer
11.2.1 Bayer Company Detail
11.2.2 Bayer Business Overview
11.2.3 Bayer Psoriatic Arthritis Therapeutics Introduction
11.2.4 Bayer Revenue in Psoriatic Arthritis Therapeutics Business (2019-2024)
11.2.5 Bayer Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Psoriatic Arthritis Therapeutics Introduction
11.3.4 Novartis Revenue in Psoriatic Arthritis Therapeutics Business (2019-2024)
11.3.5 Novartis Recent Development
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Detail
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories Psoriatic Arthritis Therapeutics Introduction
11.4.4 Abbott Laboratories Revenue in Psoriatic Arthritis Therapeutics Business (2019-2024)
11.4.5 Abbott Laboratories Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Detail
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Psoriatic Arthritis Therapeutics Introduction
11.5.4 Sanofi Revenue in Psoriatic Arthritis Therapeutics Business (2019-2024)
11.5.5 Sanofi Recent Development
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Detail
11.6.2 Bristol-Myers Squibb Business Overview
11.6.3 Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Introduction
11.6.4 Bristol-Myers Squibb Revenue in Psoriatic Arthritis Therapeutics Business (2019-2024)
11.6.5 Bristol-Myers Squibb Recent Development
11.7 Janssen Biotech
11.7.1 Janssen Biotech Company Detail
11.7.2 Janssen Biotech Business Overview
11.7.3 Janssen Biotech Psoriatic Arthritis Therapeutics Introduction
11.7.4 Janssen Biotech Revenue in Psoriatic Arthritis Therapeutics Business (2019-2024)
11.7.5 Janssen Biotech Recent Development
11.8 Amgen
11.8.1 Amgen Company Detail
11.8.2 Amgen Business Overview
11.8.3 Amgen Psoriatic Arthritis Therapeutics Introduction
11.8.4 Amgen Revenue in Psoriatic Arthritis Therapeutics Business (2019-2024)
11.8.5 Amgen Recent Development
11.9 UCB
11.9.1 UCB Company Detail
11.9.2 UCB Business Overview
11.9.3 UCB Psoriatic Arthritis Therapeutics Introduction
11.9.4 UCB Revenue in Psoriatic Arthritis Therapeutics Business (2019-2024)
11.9.5 UCB Recent Development
11.10 AbbVie
11.10.1 AbbVie Company Detail
11.10.2 AbbVie Business Overview
11.10.3 AbbVie Psoriatic Arthritis Therapeutics Introduction
11.10.4 AbbVie Revenue in Psoriatic Arthritis Therapeutics Business (2019-2024)
11.10.5 AbbVie Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
